Extracorporeal cardiopulmonary resuscitation for refractory OHCA: lessons from three randomized controlled trials-the trialists' view

Eur Heart J Acute Cardiovasc Care. 2023 Aug 24;12(8):540-547. doi: 10.1093/ehjacc/zuad071.

Abstract

Extracorporeal cardiopulmonary resuscitation is a promising treatment for refractory out-of-hospital cardiac arrest. Three recent randomized trials (ARREST trial, Prague OHCA study, and INCEPTION trial) that addressed the clinical benefit of extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest yielded seemingly diverging results. The evidence for extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest, derived from three recent randomized controlled trials, is not contradictory but rather complementary. Excellent results can be achieved with a very high level of dedication, provided that strict selection criteria are applied. However, pragmatic implementation of extracorporeal cardiopulmonary resuscitation does not necessarily lead to improved outcome of refractory out-of-hospital cardiac arrest. Centres that are performing extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest or aspire to do so should critically evaluate whether they are able to meet the pre-requisites that are needed to conduct an effective extracorporeal cardiopulmonary resuscitation programme.

Keywords: Efficacy and effectiveness; Extracorporeal cardiopulmonary resuscitation; Randomized controlled trials; Review.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cardiopulmonary Resuscitation*
  • Humans
  • Out-of-Hospital Cardiac Arrest* / therapy
  • Randomized Controlled Trials as Topic